Targeting of LAK activity to CEA-expressing tumor cells with an anti-CEA scFv/IL-2 fusion protein

Anticancer Research

Volumn 21, Issue 3 B, 2001, Pages 1673-1680

  Liao, S ^a   Khare, P D ^a   Arakawa, F ^a   Kuroki, M ^a   Hirose, Y ^a   Fujimura, S ^a   Tomita, Y ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

CEA; Fusion protein; IL 2; Immunotherapy; scFv

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY; HYBRID PROTEIN; MONOCLONAL ANTIBODY F11 39; RECOMBINANT INTERLEUKIN 2; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOTHERAPY; CELL SURFACE; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; HYBRIDOMA; IMMUNOGLOBULIN VARIABLE REGION; LYMPHOKINE ACTIVATED KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RECOMBINANT DNA TECHNOLOGY; TUMOR CELL;

ANIMALS; BLOTTING, WESTERN; CARCINOEMBRYONIC ANTIGEN; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLOW CYTOMETRY; HUMANS; HYBRIDOMAS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN FRAGMENTS; INTERLEUKIN-2; MICE; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034908372     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Antibody-interleukin 2 fusion proteins: A new approach to cancer therapy
2. Expression of genetically engineered immunoconjugates of lymphotoxin and a chimeric anti-ganglioside GD2 antibody
3. Recombinant Fv immunotoxins and Fv fragments as novel agents for cancer therapy and diagnosis
4. A recombinant antibody-interleukin 2 fusion protein suppresses growth of hepatic human neuroblastoma metastases in severe combined immunodeficiency mice
5. T cell-mediated eradication of murine metastatic melanoma induced by targeted interleukin 2 therapy
6. Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrow
7. Single-chain antigen-binding proteins
8. A recombinant single chain antibody interleukin-2 fusion protein
9. Cytokines in cancer therapy
10. Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer
11. Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibody
12. Targeting and therapy of carcinoembryonic antigen- expressing tumors in transgenic mice with an antibody- interleukin 2 fusion protein
13. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule
14. The carcinoembryonic antigen (CEA) family: Structures, suggested functions and expression in normal and malignant tissues
15. Biochemical characterization of 25 distinct carcinoembryonic antigen (CEA) epitopes recognized by 57 monoclonal antibodies and categorized into seven groups in terms of domain structure of the CEA molecule
16. Highly effective extraction of carcinoembryonic antigen with phosphatidylinositol-specific phospholipase C
17. Construction and expression of two mouse-human chimeric antibodies with high specificity and affinity for carcinoembryonic antigen
18. Engineering hybrid genes without the use of restriction enzymes: Gene splicing by overlap extension
19. In vivo tumor targeting of a recombinant single-chain antigen-binding protein
20. Molecular analysis of stimulatory anti-thyrotropin receptor antibodies (TSAbs) involved in Graves' disease. Isolation and reconstruction of antibody genes and production of monoclonal TSAbs
21. In vitro production of monoclonal antibodies in high concentration in a new and easy to handle modular minifermenter
22. Purification and characterization of carcinoembryonic antigen-related antigens in normal adult feces
23. Epitope mapping of the carcinoembryonic antigen with various related recombinant proteins expressed in Chinese hamster ovary cells and 25 distinct monoclonal antibodies
24. A rapid colorimetric assay for carcinoembryonic antigen (CEA)-mediated cell adhesion and analysis of CEA domains involved in the adhesion
25. Tumor growth suppression by a mouse/human chimeric anti-CEA antibody and lymphokine-activated killer cells in vitro and in SCID mouse xenograft model
26. Eradication of established hepatic human neuroblastoma metastases in mice with severe combined immunodeficiency by antibody-targeted interleukin-2
27. Eradication of human hepatic and pulmonary melanoma metastases in SCID mice by antibody-interleukin 2 fusion proteins
28. Antibody-targeted interleukin 2 stimulates T-cell killing of autologous tumor cells
29. Single-chain Fv antibodies for targeting cancer therapy
30. Enhanced tumor uptake of macromolecules induced by a novel vasoactive interleukin 2 immunoconjugate
31. Histamine, leukotriene C4 and interleukin-2 increase antibody uptake into a human carcinoma xenograft model